US Stock MarketDetailed Quotes

LEXX Lexaria Bioscience

Watchlist
  • 1.230
  • -0.120-8.90%
Trading Apr 28 15:27 ET
21.60MMarket Cap-2.02P/E (TTM)

Lexaria Bioscience Key Stats

Lexaria Bioscience Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 174.000K--
--2025/Q3-- / 174.000K--
--2025/Q2174.000K / 91.330K--
--2025/Q1183.920K / 100.000K--
--2024/Q484.000K / 100.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 174.000K--
--2025/Q3-- / 174.000K--
--2025/Q2174.000K / 91.330K--
--2025/Q1183.920K / 100.000K--
--2024/Q484.000K / 100.000K--

Unlock Free Earnings Estimates

Lexaria Bioscience Earnings Reports

Read more

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More